cefazolin has been researched along with Skin Diseases, Bacterial in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inaoki, A; Inaoki, M; Nishijima, C | 1 |
| Ari, S; Dal, T; Dayan, S; Dursun, B; Kaya, S; Kortak, MZ; Tekin, R | 1 |
| Adamson, RT; Amara, S; Huang, X; Lew, I | 1 |
| Boucher, HW; Corey, GR; Stryjewski, ME | 1 |
| DiNubile, MJ | 1 |
| Misago, N; Nagasawa, K; Narisawa, Y; Tada, Y | 1 |
| Aiken, S; Cassano, KB; Chirurgi, VA; Edelstein, H; Karp, R; McCabe, RE; Oster, SE | 1 |
| Bolash, NK; Liu, HH; Lynch, RA; McAnany, ME | 1 |
| Barriere, SL; Dunn, DL; Graham, DR; Kreter, B; Nichols, RL; Rodgers, A; Wilson, SE; Zervos, M | 1 |
3 trial(s) available for cefazolin and Skin Diseases, Bacterial
| Article | Year |
|---|---|
Randomized comparison trial of teicoplanin i.v., teicoplanin i.m., and cefazolin therapy for skin and soft tissue infections caused by gram-positive bacteria.
Topics: Cefazolin; Connective Tissue Diseases; Female; Gram-Positive Bacterial Infections; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Skin Diseases, Bacterial; Teicoplanin; Treatment Outcome | 1994 |
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 1995 |
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Gr
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Oxacillin; Penicillins; Skin Diseases, Bacterial; Vancomycin; Virginiamycin | 1999 |
6 other study(ies) available for cefazolin and Skin Diseases, Bacterial
| Article | Year |
|---|---|
Factors that affect the duration of antimicrobial therapy for cellulitis.
Topics: Administration, Intravenous; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Cefazolin; Cellulitis; Diabetes Complications; Female; Humans; Japan; Length of Stay; Male; Middle Aged; Risk Factors; Skin Diseases, Bacterial | 2018 |
Evaluation of cutaneous palpebral anthrax.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Cefazolin; Child; Child, Preschool; Ciprofloxacin; Eye; Female; Humans; Infant; Male; Middle Aged; Penicillins; Skin Diseases, Bacterial; Sulbactam; Young Adult | 2013 |
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Female; Hospitalization; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Skin Diseases, Bacterial; Skin Diseases, Infectious; Sulbactam; Treatment Outcome; Vancomycin | 2013 |
Reply to DiNubile.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Female; Glycopeptides; Humans; Male; Methicillin Resistance; Skin Diseases, Bacterial; Staphylococcal Infections; Vancomycin | 2015 |
Trials and tribulations of noninferiority: caveat emptor.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Female; Glycopeptides; Humans; Male; Methicillin Resistance; Skin Diseases, Bacterial; Staphylococcal Infections; Vancomycin | 2015 |
Palisaded neutrophilic granulomatous dermatitis caused by cellulitis in a patient with systemic lupus erythematosus.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; C-Reactive Protein; Cefazolin; Cellulitis; Dermatitis; Female; Histiocytosis; Humans; Lupus Erythematosus, Systemic; Prednisolone; Skin Diseases, Bacterial; Treatment Outcome | 2011 |